search
insulin
Trends
- 1Americans Set to Lose Access to Canadian Prescription Drugs●Americans Are About to Lose Access to Prescriptions from Canada
The Wall Street Journal reports that Americans who rely on cheaper prescription medications imported from Canada are about to lose that access, following a US Customs crackdown on personal drug imports. Many patients have long bought medicines like insulin across the border at lower prices, and the change is expected to raise costs for those affected.
- 2Pancreatic Cells Could Be One Genetic Tweak From Treating Diabetes▼Some Pancreatic Cells Are Just One Genetic Tweak Away From Treating Diabetes https:// fed.brid.gy/r/https://www.wire d.c
A Wired report says researchers have found that some pancreatic cells may be just one genetic modification away from producing insulin, offering a potential new route to treating diabetes. The finding suggests certain cells in the pancreas could be reprogrammed to compensate for lost insulin-producing beta cells. Scientists and health commentators are sharing the study as a promising, though still early, development in diabetes research.
- 3Iran faces shortages of 800 medicines amid sanctions and war costs●A Hebrew newspaper reports that US sanctions, inflation, currency shortages, and the costs of war have exacerbated Iran'
A Hebrew newspaper reports that Iran's pharmaceutical crisis has worsened, with shortages affecting roughly 800 types of medication, including drugs for cancer, heart conditions, migraines and insulin. The report attributes the crisis to US sanctions, high inflation, currency shortages and the financial burden of war, leaving patients struggling to obtain essential treatments.
- 4The End of Insulin Injections? Scientists Pursue Needle-Free Medicine▼The End of Insulin Injections? How Scientists Are Making Medicine Needle-Free
National Geographic reports on scientific efforts to replace insulin injections with needle-free alternatives, a change that could affect millions of people with diabetes who rely on daily injections. Researchers are exploring new delivery methods that would remove the need for needles in administering insulin and potentially other medicines.
- 5Israeli startup DreaMed wins FDA nod for insulin-dosing app▼Israeli startup DreaMed gets FDA approval for app that adjusts insulin doses for Type 2 diabetes
Israeli medtech startup DreaMed Diabetes has received FDA approval for an app that automatically adjusts insulin doses for people with Type 2 diabetes. The clearance lets the company bring its digital insulin-management tool to American patients, extending technology previously aimed at Type 1 diabetes. The news, reported by Calcalist, is being read as a milestone for Israeli digital health firms seeking US market entry.
- 6Israeli startup wins FDA clearance for injection-based diabetes app▼Israeli startup develops injection-based diabetes app, receives FDA clearance
An Israeli startup has received FDA clearance for an app designed to support people who manage diabetes with insulin injections. The digital tool aims to help patients track and manage their injection-based treatment, and its clearance means it can now be marketed in the United States. The news was reported by The Jerusalem Post and highlights Israel's growing health-tech sector.
- 7Pancreatic Cells One Genetic Tweak From Treating Diabetes●Some Pancreatic Cells Are Just One Genetic Tweak Away From Treating Diabetes https://www.wired.com/story/pancreatic-cell
New research reported by Wired suggests some pancreatic cells could be converted into insulin-producing cells through a single genetic modification, offering a potential new avenue for treating diabetes. The findings point to reprogramming existing cells rather than replacing them, a possibility researchers say could one day change how the disease is managed.
- 8FDA approves Onswik, a once-weekly insulin for type 2 diabetes●The FDA approved Onswik, a once-weekly insulin for type 2 diabetes, but not for type 1. What the trials showed and the s
The FDA has approved Onswik, a once-weekly insulin intended for adults with type 2 diabetes. It was not approved for type 1 diabetes. Coverage highlights what the clinical trials showed about effectiveness and the side effects patients should know about. The approval is drawing attention as a potential convenience shift for diabetes management, reducing injections from daily to weekly.
- 9
The American Diabetes Association has released new guidance on the use of diabetes technology in primary care, aimed at helping family doctors and general practitioners make better use of tools such as continuous glucose monitors and insulin pumps. The guidance is intended to close the gap between specialist care and everyday practice as these devices become more widespread among patients.